 | Form 4 Filings | Insider Buys | Significant Buys | Penny Stocks Insider Buying | Insider Sales |
| Insider Buy Sell Ratios | Stock Options | Insider Trading Stock Screener | Insider Trading Graph View | Insider Watch |
Insider Trading - Kymera Therapeutics Inc. (KYMR)
| | "Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise" - Peter Lynch What is insider trading>> SPAC List: List of Special Purpose Acquisition Companies |
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2021-02-17 Sale | 2021-02-19 7:27 pm | Kymera Therapeutics Inc. | KYMR | Gollob Jared Chief Medical Officer | 22,936 | $56.42 | $1,293,936 | 84,611 (Direct) | View |
| 2021-02-22 Sale | 2021-02-24 6:44 pm | Kymera Therapeutics Inc. | KYMR | Gollob Jared Chief Medical Officer | 37,064 | $50.68 | $1,878,355 | 47,547 (Direct) | View |
| 2021-03-03 Sale | 2021-03-05 5:26 pm | Kymera Therapeutics Inc. | KYMR | Jacobs Bruce N. CFO | 20,000 | $44.78 | $895,634 | 0 (Direct) | View |
| 2021-03-08 Sale | 2021-03-08 8:01 pm | Kymera Therapeutics Inc. | KYMR | Jacobs Bruce N. CFO | 10,000 | $50.65 | $506,470 | 0 (Direct) | View |
| 2021-03-11 Sale | 2021-03-15 9:08 pm | Kymera Therapeutics Inc. | KYMR | Jacobs Bruce N. CFO | 10,000 | $60.15 | $601,528 | 0 (Direct) | View |
| 2021-03-11 Sale | 2021-03-15 9:12 pm | Kymera Therapeutics Inc. | KYMR | Gollob Jared Chief Medical Officer | 15,000 | $60.13 | $901,991 | 42,547 (Direct) | View |
| 2021-03-12 Sale | 2021-03-16 7:37 pm | Kymera Therapeutics Inc. | KYMR | ATLAS VENTURE ASSOCIATES X L.P. Atlas Venture Associates X LLC 10% Owner | 229,350 | $56.5 | $12,958,275 | 0 (Indirect Direct) | View |
| 2021-03-12 Sale | 2021-03-16 7:39 pm | Kymera Therapeutics Inc. | KYMR | Booth Bruce Director | 229,350 | $56.5 | $12,958,275 | 0 (Indirect) | View |
| 2021-04-08 Sale | 2021-04-12 6:11 pm | Kymera Therapeutics Inc. | KYMR | Mainolfi Nello CEO | 48,000 | $33.62 | $1,613,563 | 376,199 (Direct) | View |
| 2021-04-15 Sale | 2021-04-19 7:12 pm | Kymera Therapeutics Inc. | KYMR | Mainolfi Nello CEO | 5,593 | $40.26 | $225,159 | 391,199 (Direct) | View |
| 2021-04-22 Sale | 2021-04-26 5:15 pm | Kymera Therapeutics Inc. | KYMR | Mainolfi Nello CEO | 14,407 | $40.23 | $579,619 | 397,199 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2020-08-20 Option Award | 2020-08-21 6:21 pm | N/A 2030-08-19 | Kymera Therapeutics Inc. | KYMR | Jacobs Bruce N. CFO | 32,904 | $0 | 32,904 (Direct) | View |
| 2020-08-20 Option Award | 2020-08-21 6:22 pm | N/A 2030-08-19 | Kymera Therapeutics Inc. | KYMR | Horobin Joanna Director | 40,127 | $0 | 40,127 (Direct) | View |
| 2020-08-20 Option Award | 2020-08-21 6:23 pm | N/A 2030-08-19 | Kymera Therapeutics Inc. | KYMR | Hedin Andrew Director | 40,127 | $0 | 40,127 (Direct) | View |
| 2020-08-20 Option Award | 2020-08-21 6:25 pm | N/A 2030-08-19 | Kymera Therapeutics Inc. | KYMR | Hall Steven Edward Director | 40,127 | $0 | 40,127 (Direct) | View |
| 2020-08-20 Option Award | 2020-08-21 6:26 pm | N/A 2030-08-19 | Kymera Therapeutics Inc. | KYMR | Hrustanovic Gorjan Director | 40,127 | $0 | 40,127 (Direct) | View |
| 2020-08-20 Option Award | 2020-08-21 6:26 pm | N/A 2030-08-19 | Kymera Therapeutics Inc. | KYMR | Mainolfi Nello CEO | 125,399 | $0 | 125,399 (Direct) | View |
| 2020-08-20 Option Award | 2020-08-21 6:27 pm | N/A 2030-08-19 | Kymera Therapeutics Inc. | KYMR | Albers Jeffrey W. Director | 40,127 | $0 | 40,127 (Direct) | View |
| 2020-08-20 Option Award | 2020-08-21 6:28 pm | N/A 2030-08-19 | Kymera Therapeutics Inc. | KYMR | Chesworth Richard Chief Scientific Officer | 351,119 | $0 | 351,119 (Direct) | View |
| 2020-08-20 Option Award | 2020-08-21 6:28 pm | N/A 2030-08-19 | Kymera Therapeutics Inc. | KYMR | Nicholson Donald William Director | 40,127 | $0 | 40,127 (Direct) | View |
| 2020-08-20 Option Award | 2020-08-21 6:31 pm | N/A 2030-08-19 | Kymera Therapeutics Inc. | KYMR | Booth Bruce Director | 40,127 | $0 | 40,127 (Direct) | View |
| 2020-08-20 Option Award | 2020-08-21 6:31 pm | N/A 2030-08-19 | Kymera Therapeutics Inc. | KYMR | Gollob Jared Chief Medical Officer | 48,942 | $0 | 48,942 (Direct) | View |
| 2020-08-25 Conversion | 2020-08-25 4:30 pm | N/A N/A | Kymera Therapeutics Inc. | KYMR | Booth Bruce Director | 7,196,584 | $0 | 7,948,982 (Indirect) | View |
| 2020-08-25 Conversion | 2020-08-25 4:30 pm | N/A N/A | Kymera Therapeutics Inc. | KYMR | Booth Bruce Director | 1,112,686 | $0 | 1,112,686 (Indirect) | View |
| 2020-08-25 Conversion | 2020-08-25 4:30 pm | N/A N/A | Kymera Therapeutics Inc. | KYMR | Booth Bruce Director | 3,000,000 | $0 | 0 (Indirect) | View |
| 2020-08-25 Conversion | 2020-08-25 4:30 pm | N/A N/A | Kymera Therapeutics Inc. | KYMR | Booth Bruce Director | 7,000,000 | $0 | 0 (Indirect) | View |
| 2020-08-25 Conversion | 2020-08-25 4:30 pm | N/A N/A | Kymera Therapeutics Inc. | KYMR | Booth Bruce Director | 1,477,832 | $0 | 0 (Indirect) | View |
| 2020-08-25 Conversion | 2020-08-25 4:30 pm | N/A N/A | Kymera Therapeutics Inc. | KYMR | Booth Bruce Director | 1,774,624 | $0 | 0 (Indirect) | View |
| 2020-08-25 Conversion | 2020-08-25 4:30 pm | N/A N/A | Kymera Therapeutics Inc. | KYMR | Atlas Venture Fund X L.P. Atlas Venture Associates X LLC ATLAS VENTURE ASSOCIATES X L.P. Atlas Venture Associates Opportunity I L.P. Atlas Venture Associates Opportunity I LLC Atlas Venture Opportunity Fund I L.P. 10% Owner | 7,196,584 | $0 | 7,948,982 (Direct) | View |
| 2020-08-25 Conversion | 2020-08-25 4:30 pm | N/A N/A | Kymera Therapeutics Inc. | KYMR | Atlas Venture Fund X L.P. Atlas Venture Associates X LLC ATLAS VENTURE ASSOCIATES X L.P. Atlas Venture Associates Opportunity I L.P. Atlas Venture Associates Opportunity I LLC Atlas Venture Opportunity Fund I L.P. 10% Owner | 1,112,686 | $0 | 1,112,686 (Indirect) | View |
| 2020-08-25 Conversion | 2020-08-25 4:30 pm | N/A N/A | Kymera Therapeutics Inc. | KYMR | Atlas Venture Fund X L.P. Atlas Venture Associates X LLC ATLAS VENTURE ASSOCIATES X L.P. Atlas Venture Associates Opportunity I L.P. Atlas Venture Associates Opportunity I LLC Atlas Venture Opportunity Fund I L.P. 10% Owner | 3,000,000 | $0 | 0 (Direct) | View |
| 2020-08-25 Conversion | 2020-08-25 4:30 pm | N/A N/A | Kymera Therapeutics Inc. | KYMR | Atlas Venture Fund X L.P. Atlas Venture Associates X LLC ATLAS VENTURE ASSOCIATES X L.P. Atlas Venture Associates Opportunity I L.P. Atlas Venture Associates Opportunity I LLC Atlas Venture Opportunity Fund I L.P. 10% Owner | 7,000,000 | $0 | 0 (Direct) | View |
| 2020-08-25 Conversion | 2020-08-25 4:30 pm | N/A N/A | Kymera Therapeutics Inc. | KYMR | Atlas Venture Fund X L.P. Atlas Venture Associates X LLC ATLAS VENTURE ASSOCIATES X L.P. Atlas Venture Associates Opportunity I L.P. Atlas Venture Associates Opportunity I LLC Atlas Venture Opportunity Fund I L.P. 10% Owner | 1,477,832 | $0 | 0 (Direct) | View |
| 2020-08-25 Conversion | 2020-08-25 4:30 pm | N/A N/A | Kymera Therapeutics Inc. | KYMR | Atlas Venture Fund X L.P. Atlas Venture Associates X LLC ATLAS VENTURE ASSOCIATES X L.P. Atlas Venture Associates Opportunity I L.P. Atlas Venture Associates Opportunity I LLC Atlas Venture Opportunity Fund I L.P. 10% Owner | 1,774,624 | $0 | 0 (Indirect) | View |
| 2020-08-25 Conversion | 2020-08-25 4:30 pm | N/A N/A | Kymera Therapeutics Inc. | KYMR | Hall Steven Edward Director | 2,192,249 | $0 | 2,192,249 (Indirect) | View |
| 2020-08-25 Conversion | 2020-08-25 4:30 pm | N/A N/A | Kymera Therapeutics Inc. | KYMR | Hall Steven Edward Director | 2,511,198 | $0 | 0 (Indirect) | View |
| 2020-08-25 Conversion | 2020-08-25 4:30 pm | N/A N/A | Kymera Therapeutics Inc. | KYMR | Hall Steven Edward Director | 985,220 | $0 | 0 (Indirect) | View |
| 2020-08-25 Conversion | 2020-08-25 4:39 pm | N/A N/A | Kymera Therapeutics Inc. | KYMR | Redmile Group LLC Green Jeremy 10% Owner | 1,630,660 | $0 | 1,630,660 (Indirect) | View |
| 2020-08-25 Conversion | 2020-08-25 4:39 pm | N/A N/A | Kymera Therapeutics Inc. | KYMR | Redmile Group LLC Green Jeremy 10% Owner | 2,600,740 | $0 | 0 (Indirect) | View |
| 2020-08-25 Conversion | 2020-08-25 6:36 pm | N/A N/A | Kymera Therapeutics Inc. | KYMR | Alexandria Venture Investments LLC 10% Owner | 467,932 | $0 | 467,932 (Direct) | View |
| 2020-08-25 Conversion | 2020-08-25 6:36 pm | N/A N/A | Kymera Therapeutics Inc. | KYMR | Alexandria Venture Investments LLC 10% Owner | 500,000 | $0 | 0 (Direct) | View |
| 2020-08-25 Conversion | 2020-08-25 6:36 pm | N/A N/A | Kymera Therapeutics Inc. | KYMR | Alexandria Venture Investments LLC 10% Owner | 246,305 | $0 | 0 (Direct) | View |
| 2020-08-20 Conversion | 2020-08-25 6:48 pm | N/A N/A | Kymera Therapeutics Inc. | KYMR | BVF PARTNERS L P BIOTECHNOLOGY VALUE FUND L P BVF I GP LLC BIOTECHNOLOGY VALUE FUND II LP BVF II GP LLC Biotechnology Value Trading Fund OS LP BVF Partners OS Ltd. BVF GP HOLDINGS LLC BVF INC LAMPERT MARK N Director | 837,916 | $0 | 837,916 (Direct) | View |
| 2020-08-20 Option Award | 2020-08-25 6:48 pm | N/A N/A | Kymera Therapeutics Inc. | KYMR | BVF PARTNERS L P BIOTECHNOLOGY VALUE FUND L P BVF I GP LLC BIOTECHNOLOGY VALUE FUND II LP BVF II GP LLC Biotechnology Value Trading Fund OS LP BVF Partners OS Ltd. BVF GP HOLDINGS LLC BVF INC LAMPERT MARK N Director | 521,193 | $20 | 1,359,109 (Direct) | View |
| 2020-08-20 Conversion | 2020-08-25 6:48 pm | N/A N/A | Kymera Therapeutics Inc. | KYMR | BVF PARTNERS L P BIOTECHNOLOGY VALUE FUND L P BVF I GP LLC BIOTECHNOLOGY VALUE FUND II LP BVF II GP LLC Biotechnology Value Trading Fund OS LP BVF Partners OS Ltd. BVF GP HOLDINGS LLC BVF INC LAMPERT MARK N Director | 627,598 | $0 | 627,598 (Direct) | View |
| 2020-08-20 Option Award | 2020-08-25 6:48 pm | N/A N/A | Kymera Therapeutics Inc. | KYMR | BVF PARTNERS L P BIOTECHNOLOGY VALUE FUND L P BVF I GP LLC BIOTECHNOLOGY VALUE FUND II LP BVF II GP LLC Biotechnology Value Trading Fund OS LP BVF Partners OS Ltd. BVF GP HOLDINGS LLC BVF INC LAMPERT MARK N Director | 389,709 | $20 | 1,017,307 (Direct) | View |
| 2020-08-20 Conversion | 2020-08-25 6:48 pm | N/A N/A | Kymera Therapeutics Inc. | KYMR | BVF PARTNERS L P BIOTECHNOLOGY VALUE FUND L P BVF I GP LLC BIOTECHNOLOGY VALUE FUND II LP BVF II GP LLC Biotechnology Value Trading Fund OS LP BVF Partners OS Ltd. BVF GP HOLDINGS LLC BVF INC LAMPERT MARK N Director | 113,290 | $0 | 113,290 (Direct) | View |
| 2020-08-20 Option Award | 2020-08-25 6:48 pm | N/A N/A | Kymera Therapeutics Inc. | KYMR | BVF PARTNERS L P BIOTECHNOLOGY VALUE FUND L P BVF I GP LLC BIOTECHNOLOGY VALUE FUND II LP BVF II GP LLC Biotechnology Value Trading Fund OS LP BVF Partners OS Ltd. BVF GP HOLDINGS LLC BVF INC LAMPERT MARK N Director | 67,791 | $20 | 181,081 (Direct) | View |
| 2020-08-20 Option Award | 2020-08-25 6:48 pm | N/A N/A | Kymera Therapeutics Inc. | KYMR | BVF PARTNERS L P BIOTECHNOLOGY VALUE FUND L P BVF I GP LLC BIOTECHNOLOGY VALUE FUND II LP BVF II GP LLC Biotechnology Value Trading Fund OS LP BVF Partners OS Ltd. BVF GP HOLDINGS LLC BVF INC LAMPERT MARK N Director | 40,127 | $0 | 40,127 (Indirect) | View |
| 2020-08-20 Conversion | 2020-08-25 6:48 pm | N/A N/A | Kymera Therapeutics Inc. | KYMR | BVF PARTNERS L P BIOTECHNOLOGY VALUE FUND L P BVF I GP LLC BIOTECHNOLOGY VALUE FUND II LP BVF II GP LLC Biotechnology Value Trading Fund OS LP BVF Partners OS Ltd. BVF GP HOLDINGS LLC BVF INC LAMPERT MARK N Director | 1,336,390 | $0 | 0 (Direct) | View |
| 2020-08-20 Conversion | 2020-08-25 6:48 pm | N/A N/A | Kymera Therapeutics Inc. | KYMR | BVF PARTNERS L P BIOTECHNOLOGY VALUE FUND L P BVF I GP LLC BIOTECHNOLOGY VALUE FUND II LP BVF II GP LLC Biotechnology Value Trading Fund OS LP BVF Partners OS Ltd. BVF GP HOLDINGS LLC BVF INC LAMPERT MARK N Director | 1,000,955 | $0 | 0 (Direct) | View |
| 2020-08-20 Conversion | 2020-08-25 6:48 pm | N/A N/A | Kymera Therapeutics Inc. | KYMR | BVF PARTNERS L P BIOTECHNOLOGY VALUE FUND L P BVF I GP LLC BIOTECHNOLOGY VALUE FUND II LP BVF II GP LLC Biotechnology Value Trading Fund OS LP BVF Partners OS Ltd. BVF GP HOLDINGS LLC BVF INC LAMPERT MARK N Director | 180,686 | $0 | 0 (Direct) | View |
| 2020-08-25 Conversion | 2020-08-27 4:12 pm | N/A N/A | Kymera Therapeutics Inc. | KYMR | Wellington Biomedical Innovation Master Investors (Cayman) I L.P. 10% Owner | 959,211 | $0 | 959,211 (Direct) | View |
| 2020-08-25 Conversion | 2020-08-27 4:12 pm | N/A N/A | Kymera Therapeutics Inc. | KYMR | Wellington Biomedical Innovation Master Investors (Cayman) I L.P. 10% Owner | 1,529,847 | $0 | 0 (Direct) | View |
| 2020-09-04 Option Award | 2020-09-09 4:51 pm | N/A 2030-09-03 | Kymera Therapeutics Inc. | KYMR | Esposito Pamela Director | 40,127 | $0 | 40,127 (Direct) | View |
| 2021-02-18 Other | 2021-02-22 4:58 pm | N/A N/A | Kymera Therapeutics Inc. | KYMR | Atlas Venture Fund X L.P. 10% Owner | 1,063,351 | $0 | 6,885,631 (Direct) | View |
| 2021-03-01 Option Award | 2021-03-03 4:27 pm | N/A 2031-02-28 | Kymera Therapeutics Inc. | KYMR | Jacobs Bruce N. CFO | 140,000 | $0 | 140,000 (Direct) | View |
| 2021-03-01 Option Award | 2021-03-03 4:52 pm | N/A 2031-02-28 | Kymera Therapeutics Inc. | KYMR | Chesworth Richard Chief Scientific Officer | 60,000 | $0 | 60,000 (Direct) | View |
| 2021-03-01 Option Award | 2021-03-03 4:54 pm | N/A 2031-02-28 | Kymera Therapeutics Inc. | KYMR | Mainolfi Nello CEO | 375,000 | $0 | 375,000 (Direct) | View |
| 2021-03-01 Option Award | 2021-03-03 4:57 pm | N/A 2031-02-28 | Kymera Therapeutics Inc. | KYMR | Gollob Jared Chief Medical Officer | 100,000 | $0 | 100,000 (Direct) | View |
| 2021-03-03 Exercise | 2021-03-05 5:26 pm | N/A N/A | Kymera Therapeutics Inc. | KYMR | Jacobs Bruce N. CFO | 20,000 | $2.08 | 20,000 (Direct) | View |
| 2021-03-03 Exercise | 2021-03-05 5:26 pm | N/A 2030-08-19 | Kymera Therapeutics Inc. | KYMR | Jacobs Bruce N. CFO | 20,000 | $0 | 254,061 (Direct) | View |
| 2021-03-08 Exercise | 2021-03-08 8:01 pm | N/A N/A | Kymera Therapeutics Inc. | KYMR | Jacobs Bruce N. CFO | 10,000 | $2.08 | 10,000 (Direct) | View |
| 2021-03-08 Exercise | 2021-03-08 8:01 pm | N/A 2030-08-19 | Kymera Therapeutics Inc. | KYMR | Jacobs Bruce N. CFO | 10,000 | $0 | 244,061 (Direct) | View |
| 2021-03-11 Exercise | 2021-03-15 9:08 pm | N/A N/A | Kymera Therapeutics Inc. | KYMR | Jacobs Bruce N. CFO | 1,805 | $2.08 | 1,805 (Direct) | View |
| 2021-03-11 Exercise | 2021-03-15 9:08 pm | N/A N/A | Kymera Therapeutics Inc. | KYMR | Jacobs Bruce N. CFO | 8,195 | $2.08 | 8,195 (Direct) | View |
| 2021-03-11 Exercise | 2021-03-15 9:08 pm | N/A 2030-08-19 | Kymera Therapeutics Inc. | KYMR | Jacobs Bruce N. CFO | 1,805 | $0 | 242,256 (Direct) | View |
| 2021-03-11 Exercise | 2021-03-15 9:08 pm | N/A 2030-08-19 | Kymera Therapeutics Inc. | KYMR | Jacobs Bruce N. CFO | 8,195 | $0 | 234,061 (Direct) | View |
| 2021-03-11 Exercise | 2021-03-15 9:12 pm | N/A N/A | Kymera Therapeutics Inc. | KYMR | Gollob Jared Chief Medical Officer | 2,200 | $1.31 | 49,747 (Direct) | View |
| 2021-03-11 Exercise | 2021-03-15 9:12 pm | N/A N/A | Kymera Therapeutics Inc. | KYMR | Gollob Jared Chief Medical Officer | 7,800 | $1.31 | 52,852 (Direct) | View |
| 2021-03-11 Exercise | 2021-03-15 9:12 pm | N/A 2028-10-31 | Kymera Therapeutics Inc. | KYMR | Gollob Jared Chief Medical Officer | 2,200 | $0 | 67,807 (Direct) | View |
| 2021-03-11 Exercise | 2021-03-15 9:12 pm | N/A 2028-10-31 | Kymera Therapeutics Inc. | KYMR | Gollob Jared Chief Medical Officer | 7,800 | $0 | 60,007 (Direct) | View |
| 2021-03-12 Option Award | 2021-03-16 5:22 pm | N/A 2031-03-11 | Kymera Therapeutics Inc. | KYMR | Ridloff Elena Director | 40,127 | $0 | 40,127 (Direct) | View |
| 2021-04-08 Exercise | 2021-04-12 6:11 pm | N/A N/A | Kymera Therapeutics Inc. | KYMR | Mainolfi Nello CEO | 9,939 | $2.08 | 386,138 (Direct) | View |
| 2021-04-08 Exercise | 2021-04-12 6:11 pm | N/A N/A | Kymera Therapeutics Inc. | KYMR | Mainolfi Nello CEO | 22,794 | $2.08 | 398,993 (Direct) | View |
| 2021-04-08 Exercise | 2021-04-12 6:11 pm | N/A N/A | Kymera Therapeutics Inc. | KYMR | Mainolfi Nello CEO | 15,267 | $2.08 | 391,466 (Direct) | View |
| 2021-04-08 Exercise | 2021-04-12 6:11 pm | N/A 2019-11-13 | Kymera Therapeutics Inc. | KYMR | Mainolfi Nello CEO | 9,939 | $0 | 282,786 (Direct) | View |
| 2021-04-08 Exercise | 2021-04-12 6:11 pm | N/A 2019-11-13 | Kymera Therapeutics Inc. | KYMR | Mainolfi Nello CEO | 22,794 | $0 | 259,992 (Direct) | View |
| 2021-04-08 Exercise | 2021-04-12 6:11 pm | N/A 2019-11-13 | Kymera Therapeutics Inc. | KYMR | Mainolfi Nello CEO | 15,267 | $0 | 244,725 (Direct) | View |
| 2021-04-13 Exercise | 2021-04-13 6:37 pm | N/A N/A | Kymera Therapeutics Inc. | KYMR | Jacobs Bruce N. CFO | 7,000 | $2.08 | 7,000 (Direct) | View |
| 2021-04-13 Exercise | 2021-04-13 6:37 pm | N/A 2029-08-28 | Kymera Therapeutics Inc. | KYMR | Jacobs Bruce N. CFO | 7,000 | $0 | 229,899 (Direct) | View |
| 2021-04-13 Exercise | 2021-04-13 6:39 pm | N/A N/A | Kymera Therapeutics Inc. | KYMR | Mainolfi Nello CEO | 15,000 | $2.08 | 391,199 (Direct) | View |
| 2021-04-13 Exercise | 2021-04-13 6:39 pm | N/A 2029-05-22 | Kymera Therapeutics Inc. | KYMR | Mainolfi Nello CEO | 15,000 | $0 | 157,424 (Direct) | View |
| 2021-04-15 Exercise | 2021-04-19 7:12 pm | N/A N/A | Kymera Therapeutics Inc. | KYMR | Mainolfi Nello CEO | 4,940 | $2.08 | 396,139 (Direct) | View |
| 2021-04-15 Exercise | 2021-04-19 7:12 pm | N/A N/A | Kymera Therapeutics Inc. | KYMR | Mainolfi Nello CEO | 653 | $2.08 | 391,852 (Direct) | View |
| 2021-04-15 Exercise | 2021-04-19 7:12 pm | N/A N/A | Kymera Therapeutics Inc. | KYMR | Mainolfi Nello CEO | 6,000 | $2.08 | 397,199 (Direct) | View |
| 2021-04-15 Exercise | 2021-04-19 7:12 pm | N/A 2029-11-13 | Kymera Therapeutics Inc. | KYMR | Mainolfi Nello CEO | 4,940 | $0 | 239,785 (Direct) | View |
| 2021-04-15 Exercise | 2021-04-19 7:12 pm | N/A 2029-11-13 | Kymera Therapeutics Inc. | KYMR | Mainolfi Nello CEO | 653 | $0 | 239,132 (Direct) | View |
| 2021-04-15 Exercise | 2021-04-19 7:12 pm | N/A 2029-05-22 | Kymera Therapeutics Inc. | KYMR | Mainolfi Nello CEO | 6,000 | $0 | 151,424 (Direct) | View |
| 2021-04-22 Exercise | 2021-04-26 5:15 pm | N/A N/A | Kymera Therapeutics Inc. | KYMR | Mainolfi Nello CEO | 10,959 | $2.08 | 408,158 (Direct) | View |
| 2021-04-22 Exercise | 2021-04-26 5:15 pm | N/A N/A | Kymera Therapeutics Inc. | KYMR | Mainolfi Nello CEO | 680 | $2.08 | 397,879 (Direct) | View |
| 2021-04-22 Exercise | 2021-04-26 5:15 pm | N/A N/A | Kymera Therapeutics Inc. | KYMR | Mainolfi Nello CEO | 2,768 | $2.08 | 399,967 (Direct) | View |
| 2021-04-22 Exercise | 2021-04-26 5:15 pm | N/A 2029-11-13 | Kymera Therapeutics Inc. | KYMR | Mainolfi Nello CEO | 10,959 | $0 | 228,173 (Direct) | View |
| 2021-04-22 Exercise | 2021-04-26 5:15 pm | N/A 2029-11-13 | Kymera Therapeutics Inc. | KYMR | Mainolfi Nello CEO | 680 | $0 | 227,493 (Direct) | View |
| 2021-04-22 Exercise | 2021-04-26 5:15 pm | N/A 2029-11-13 | Kymera Therapeutics Inc. | KYMR | Mainolfi Nello CEO | 2,768 | $0 | 224,725 (Direct) | View |